Base de dados : MEDLINE
Pesquisa : Doenças and Sexualmente and Transmissíveis [Palavras]
Referências encontradas : 20128 [refinar]
Mostrando: 1 .. 10   no formato [Detalhado]

página 1 de 2013 ir para página                         

  1 / 20128 MEDLINE  
              next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:24613084
[Au] Autor:Buchbinder SP; Glidden DV; Liu AY; McMahan V; Guanira JV; Mayer KH; Goicochea P; Grant RM
[Ad] Endereço:Bridge HIV, San Francisco Department of Public Health, San Francisco, CA, USA; Department of Medicine, University of California, San Francisco, CA, USA; Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA. Electronic address: susan.buchbinder@sfdph.org....
[Ti] Título:HIV pre-exposure prophylaxis in men who have sex with men and transgender women: a secondary analysis of a phase 3 randomised controlled efficacy trial.
[So] Source:Lancet Infect Dis;14(6):468-75, 2014 Jun.
[Is] ISSN:1474-4457
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:BACKGROUND: For maximum effect pre-exposure prophylaxis should be targeted to the subpopulations that account for the largest proportion of infections (population-attributable fraction [PAF]) and for whom the number needed to treat (NNT) to prevent infection is lowest. We aimed to estimate the PAF and NNT of participants in the iPrEx (Pre-Exposure Prophylaxis Initiative) trial. METHODS: The iPrEx study was a randomised controlled efficacy trial of pre-exposure prophylaxis with coformulated tenofovir disoproxil fumarate and emtricitabine in 2499 men who have sex with men (MSM) and transgender women. Participants aged 18 years or older who were male at birth were enrolled from 11 trial sites in Brazil, Ecuador, Peru, South Africa, Thailand, and the USA. Participants were randomly assigned (1:1) to receive either a pill with active pre-exposure prophylaxis or placebo, taken daily. We calculated the association between demographic and risk behaviour during screening and subsequent seroconversion among placebo recipients using a Poisson model, and we calculated the PAF and NNT for risk behaviour subgroups. The iPrEx trial is registered with ClinicalTrials.gov, NCT00458393. FINDINGS: Patients were enrolled between July 10, 2007, and Dec 17, 2009, and were followed up until Nov 21, 2010. Of the 2499 MSM and transgender women in the iPrEx trial, 1251 were assigned to pre-exposure prophylaxis and 1248 to placebo. 83 of 1248 patients in the placebo group became infected with HIV during follow-up. Participants reporting receptive anal intercourse without a condom seroconverted significantly more often than those reporting no anal sex without a condom (adjusted hazard ratio [AHR] 5·11, 95% CI 1·55-16·79). The overall PAF for MSM and transgender women reporting receptive anal intercourse without a condom was 64% (prevalence 60%). Most of this risk came from receptive anal intercourse without a condom with partners with unknown serostatus (PAF 53%, prevalence 54%, AHR 4·76, 95% CI 1·44-15·71); by contrast, the PAF for receptive anal intercourse without a condom with an HIV-positive partner was 1% (prevalence 1%, AHR 7·11, 95% CI 0·70-72·75). The overall NNT per year for the cohort was 62 (95% CI 44-147). NNTs were lowest for MSM and transgender women self-reporting receptive anal intercourse without a condom (NNT 36), cocaine use (12), or a sexually transmitted infection (41). Having one partner and insertive anal sex without a condom had the highest NNTs (100 and 77, respectively). INTERPRETATION: Pre-exposure prophylaxis may be most effective at a population level if targeted toward MSM and transgender women who report receptive anal intercourse without a condom, even if they perceive their partners to be HIV negative. Substance use history and testing for STIs should also inform individual decisions to start pre-exposure prophylaxis. Consideration of the PAF and NNT can aid in discussion of the benefits and risks of pre-exposure prophylaxis with MSM and transgender women. FUNDING: National Institute of Allergy and Infectious Diseases and the Bill & Melinda Gates Foundation.
[Mh] Termos MeSH primário: Antivirais/administração & dosagem
Infecções por HIV/prevenção & controle
Homossexualidade Masculina/estatística & dados numéricos
Doenças Sexualmente Transmissíveis/prevenção & controle
Pessoas Transgênero/estatística & dados numéricos
[Mh] Termos MeSH secundário: Adenina/administração & dosagem
Adenina/análogos & derivados
Adolescente
Adulto
Preservativos/utilização
Desoxicitidina/administração & dosagem
Desoxicitidina/análogos & derivados
Feminino
Soropositividade para HIV
Humanos
Masculino
Ácidos Fosforosos/administração & dosagem
Parceiros Sexuais
África do Sul
América do Sul
Tailândia
Estados Unidos
Adulto Jovem
[Pt] Tipo de publicação:CLINICAL TRIAL, PHASE III; JOURNAL ARTICLE; RANDOMIZED CONTROLLED TRIAL; RESEARCH SUPPORT, NON-U.S. GOV'T
[Nm] Nome de substância:
0 (9-(2-((bis(pivaloyloxymethoxy)phosphinoyl)methoxy)propyl)adenine); 0 (Antiviral Agents); 0 (Phosphorous Acids); 0 (emtricitabine); 0W860991D6 (Deoxycytidine); JAC85A2161 (Adenine)
[Em] Mês de entrada:1407
[Cu] Atualização por classe:140815
[Lr] Data última revisão:
140815
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:140522
[St] Status:MEDLINE


  2 / 20128 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:24613083
[Au] Autor:Baeten JM; Heffron R
[Ad] Endereço:Department of Global Health, University of Washington, Seattle, WA 98104, USA; Department of Medicine, University of Washington, Seattle, WA 98104, USA; Department of Epidemiology, University of Washington, Seattle, WA 98104, USA. Electronic address: jbaeten@uw.edu.
[Ti] Título:Pre-exposure prophylaxis to intensify the fight against HIV.
[So] Source:Lancet Infect Dis;14(6):443-5, 2014 Jun.
[Is] ISSN:1474-4457
[Cp] País de publicação:United States
[La] Idioma:eng
[Mh] Termos MeSH primário: Antivirais/administração & dosagem
Infecções por HIV/prevenção & controle
Homossexualidade Masculina/estatística & dados numéricos
Doenças Sexualmente Transmissíveis/prevenção & controle
Pessoas Transgênero/estatística & dados numéricos
[Mh] Termos MeSH secundário: Feminino
Humanos
Masculino
[Pt] Tipo de publicação:COMMENT; JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Antiviral Agents)
[Em] Mês de entrada:1407
[Cu] Atualização por classe:140815
[Lr] Data última revisão:
140815
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:140522
[St] Status:MEDLINE


  3 / 20128 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
[PMID]:24501774
[Au] Autor:Kirby T
[Ti] Título:Record highs of sexually transmitted infections in UK's MSM.
[So] Source:Lancet Infect Dis;14(1):16-7, 2014 Jan.
[Is] ISSN:1474-4457
[Cp] País de publicação:United States
[La] Idioma:eng
[Mh] Termos MeSH primário: Homossexualidade Masculina
Doenças Bacterianas Sexualmente Transmissíveis/epidemiologia
Doenças Virais Sexualmente Transmissíveis/epidemiologia
[Mh] Termos MeSH secundário: Reino Unido/epidemiologia
Humanos
Incidência
Masculino
[Pt] Tipo de publicação:NEWS
[Em] Mês de entrada:1402
[Cu] Atualização por classe:140815
[Lr] Data última revisão:
140815
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:140205
[St] Status:MEDLINE


  4 / 20128 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:24730535
[Au] Autor:Rintamaki LS; Yang ZJ
[Ad] Endereço:a Department of Communication , University at Buffalo, The State University of New York , Buffalo , New York , USA.
[Ti] Título:Advancing the extended parallel process model through the inclusion of response cost measures.
[So] Source:J Health Commun;19(7):759-74, 2014.
[Is] ISSN:1087-0415
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:This study advances the Extended Parallel Process Model through the inclusion of response cost measures, which are drawbacks associated with a proposed response to a health threat. A sample of 502 college students completed a questionnaire on perceptions regarding sexually transmitted infections and condom use after reading information from the Centers for Disease Control and Prevention on the health risks of sexually transmitted infections and the utility of latex condoms in preventing sexually transmitted infection transmission. The questionnaire included standard Extended Parallel Process Model assessments of perceived threat and efficacy, as well as questions pertaining to response costs associated with condom use. Results from hierarchical ordinary least squares regression demonstrated how the addition of response cost measures improved the predictive power of the Extended Parallel Process Model, supporting the inclusion of this variable in the model.
[Mh] Termos MeSH primário: Atitude Frente a Saúde
Preservativos/economia
Preservativos/utilização
Modelos Psicológicos
Doenças Sexualmente Transmissíveis/prevenção & controle
Doenças Sexualmente Transmissíveis/psicologia
Estudantes/psicologia
[Mh] Termos MeSH secundário: Adolescente
Centers for Disease Control and Prevention (U.S.)
Medo
Feminino
Educação em Saúde
Humanos
Análise dos Mínimos Quadrados
Masculino
Questionários
Medição de Risco
Estudantes/estatística & dados numéricos
Estados Unidos
Universidades
Adulto Jovem
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1408
[Sb] Subgrupo de revista:T
[Da] Data de entrada para processamento:140628
[St] Status:MEDLINE
[do] DOI:10.1080/10810730.2013.864722


  5 / 20128 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:24315231
[Au] Autor:Dauendorffer JN; Cavelier-Balloy B; Renaud-Vilmer C
[Ad] Endereço:Service de dermatologie, hôpital Saint-Louis, 1, avenue Claude-Vellefaux, 75010 Paris, France. Electronic address: jn.dauendorffer@free.fr.
[Ti] Título:[Circumcision and dermatology].
[Ti] Título:Circoncision et dermatologie..
[So] Source:Ann Dermatol Venereol;140(12):816-20, 2013 Dec.
[Is] ISSN:0151-9638
[Cp] País de publicação:France
[La] Idioma:fre
[Mh] Termos MeSH primário: Carcinoma de Células Escamosas/prevenção & controle
Circuncisão Masculina
Doenças do Pênis/prevenção & controle
Neoplasias Penianas/prevenção & controle
Doenças Sexualmente Transmissíveis/prevenção & controle
[Mh] Termos MeSH secundário: Adulto
Balanite/epidemiologia
Balanite/prevenção & controle
Carcinoma in Situ/epidemiologia
Carcinoma in Situ/prevenção & controle
Carcinoma de Células Escamosas/epidemiologia
Criança
Pré-Escolar
Circuncisão Masculina/efeitos adversos
Circuncisão Masculina/psicologia
Circuncisão Masculina/utilização
Cultura
Humanos
Recém-Nascido
Líquen Escleroso e Atrófico/epidemiologia
Líquen Escleroso e Atrófico/prevenção & controle
Masculino
Doenças do Pênis/epidemiologia
Neoplasias Penianas/epidemiologia
Fimose/cirurgia
Complicações Pós-Operatórias/epidemiologia
Complicações Pós-Operatórias/etiologia
Estudos Prospectivos
Religião
Doenças Sexualmente Transmissíveis/epidemiologia
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Em] Mês de entrada:1408
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:131209
[St] Status:MEDLINE


  6 / 20128 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:24315219
[Au] Autor:Halioua B
[Ad] Endereço:Service de dermatologie, institut Alfred-Fournier, 25, boulevard Saint-Jacques, 75014 Paris, France. Electronic address: haliouab@yahoo.fr.
[Ti] Título:[The twenty-first century will be religious or it will not be].
[Ti] Título:Le XXIe siècle sera religieux ou ne sera pas..
[So] Source:Ann Dermatol Venereol;140(12):753-4, 2013 Dec.
[Is] ISSN:0151-9638
[Cp] País de publicação:France
[La] Idioma:fre
[Mh] Termos MeSH primário: Carcinoma de Células Escamosas/prevenção & controle
Cristianismo
Circuncisão Masculina
Doenças do Pênis/prevenção & controle
Neoplasias Penianas/prevenção & controle
Transtornos Psicofisiológicos/diagnóstico
Comportamento Autodestrutivo/diagnóstico
Doenças Sexualmente Transmissíveis/prevenção & controle
[Mh] Termos MeSH secundário: Feminino
Humanos
Masculino
[Pt] Tipo de publicação:COMMENT; EDITORIAL
[Em] Mês de entrada:1408
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:131209
[St] Status:MEDLINE


  7 / 20128 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
PubMed Central Texto completo
[PMID]:24082165
[Au] Autor:Waldner C; Hendrick S; Chaban B; Garcia Guerra A; Griffin G; Campbell J; Hill JE
[Ad] Endereço:Department of Large Animal Clinical Sciences (Waldner, Hendrick, Garcia Guerra, Campbell), Department of Veterinary Microbiology (Chaban, Hill), Western College of Veterinary Medicine, Saskatoon, Saskatchewan S7N 5B4; Southwest Animal Health Center, Swift Current, Saskatchewan S9H 4G6 (Griffin).
[Ti] Título:Application of a new diagnostic approach to a bovine genital campylobacteriosis outbreak in a Saskatchewan beef herd.
[So] Source:Can Vet J;54(4):373-6, 2013 Apr.
[Is] ISSN:0008-5286
[Cp] País de publicação:Canada
[La] Idioma:eng
[Ab] Resumo:A new real-time quantitative polymerase chain reaction (qPCR) test was used to diagnose Campylobacter fetus subsp. venerealis infection associated with dramatic reproductive losses in a commercial cow-calf herd. The results were verified with repeated culture, phenotypic characterization of the organism and DNA sequencing. This case demonstrates the need for a practical field test for C. fetus subsp. venerealis and the importance of considering this organism as a potential cause of pregnancy failure in beef herds.
[Mh] Termos MeSH primário: Infecções por Campylobacter/veterinária
Campylobacter fetus/isolamento & purificação
Doenças dos Bovinos/microbiologia
Surtos de Doenças/veterinária
Doenças Bacterianas Sexualmente Transmissíveis/veterinária
[Mh] Termos MeSH secundário: Animais
Infecções por Campylobacter/epidemiologia
Campylobacter fetus/classificação
Bovinos
Doenças dos Bovinos/epidemiologia
Feminino
Masculino
Gravidez
Taxa de Gravidez
Saskatchewan/epidemiologia
Doenças Bacterianas Sexualmente Transmissíveis/epidemiologia
[Pt] Tipo de publicação:JOURNAL ARTICLE; RESEARCH SUPPORT, NON-U.S. GOV'T
[Em] Mês de entrada:1405
[Cu] Atualização por classe:140814
[Lr] Data última revisão:
140814
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:131001
[St] Status:MEDLINE


  8 / 20128 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
PubMed Central Texto completo
Texto completo
[PMID]:24432923
[Au] Autor:Jemmott JB; Jemmott LS; O'Leary A; Ngwane Z; Icard LD; Heeren GA; Mtose X; Carty C
[Ad] Endereço:John B. Jemmott III, G. Anita Heeren, and Craig Carty are with the Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia. John B. Jemmott III is also with the Annenberg School for Communication, University of Pennsylvania. Loretta S. Jemmott is with the School of Nursing, University of Pennsylvania. Ann O'Leary is with the Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA. Zolani Ngwane is with the Department of Anthropology, Haverford College, Haverford, PA. Larry D. Icard is with the College of Health Professionals and Social Work, Temple University, Philadelphia, PA. Xoliswa Mtose is with the Faculty of Education, University of Fort Hare, East London, South Africa.
[Ti] Título:Cluster-randomized controlled trial of an HIV/sexually transmitted infection risk-reduction intervention for South African men.
[So] Source:Am J Public Health;104(3):467-73, 2014 Mar.
[Is] ISSN:1541-0048
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:OBJECTIVES: We tested the efficacy of a sexual risk-reduction intervention for men in South Africa, where heterosexual exposure is the main mode of HIV transmission. METHODS: Matched-pairs of neighborhoods in Eastern Cape Province, South Africa, were randomly selected and within pairs randomized to 1 of 2 interventions based on social cognitive theory and qualitative research: HIV/sexually transmitted infection (STI) risk-reduction, targeting condom use, or attention-matched control, targeting health issues unrelated to sexual risks. Sexually active men aged 18 to 45 years were eligible. The primary outcome was consistent condom use in the past 3 months. RESULTS: Of 1181 participants, 1106 (93.6%) completed the 12-month follow-up. HIV and STI risk-reduction participants had higher odds of reporting consistent condom use (odds ratio [OR] = 1.32; 95% confidence interval [CI] = 1.03, 1.71) and condom use at last vaginal intercourse (OR = 1.40; 95% CI = 1.08, 1.82) than did attention-control participants, adjusting for baseline prevalence. No differences were observed on unprotected intercourse or multiple partnerships. Findings did not differ for sex with steady as opposed to casual partners. CONCLUSIONS: Behavioral interventions specifically targeting men can contribute to efforts to reduce sexual risk behaviors in South Africa.
[Mh] Termos MeSH primário: Grupo com Ancestrais do Continente Africano
Infecções por HIV/prevenção & controle
Comportamento de Redução do Risco
Sexo Seguro
Doenças Sexualmente Transmissíveis/prevenção & controle
[Mh] Termos MeSH secundário: Adolescente
Adulto
Análise por Conglomerados
Intervalos de Confiança
Seguimentos
Promoção da Saúde
Humanos
Masculino
Meia-Idade
Razão de Chances
África do Sul
Adulto Jovem
[Pt] Tipo de publicação:JOURNAL ARTICLE; RANDOMIZED CONTROLLED TRIAL; RESEARCH SUPPORT, N.I.H., EXTRAMURAL
[Em] Mês de entrada:1404
[Cu] Atualização por classe:140812
[Lr] Data última revisão:
140812
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:140213
[St] Status:MEDLINE
[do] DOI:10.2105/AJPH.2013.301578


  9 / 20128 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
[PMID]:24418917
[Au] Autor:Hatori T; Nakamura T; Tsukui S
[Ad] Endereço:Maebashi municipal public health center.
[Ti] Título:[The importance of using a test to detect Chlamydia trachomatis infection in patients undergoing counseling and testing for sexually transmitted diseases at a public health center].
[So] Source:Nihon Koshu Eisei Zasshi;60(11):691-6, 2013.
[Is] ISSN:0546-1766
[Cp] País de publicação:Japan
[La] Idioma:jpn
[Ab] Resumo:OBJECTIVES: Serum levels of antibody against Chlamydia trachomatis are used routinely to diagnose chlamydial infection among patients undergoing counseling and testing for sexually transmitted disease at public health centers in Japan, whereas tests for pathogen detection are conducted at most clinics. The objective of the present study was to evaluate the usefulness of a test for detecting C. trachomatis and to compare it with that of screening for serum chlamydia antibodies at a public health center. METHODS: Serum chlamydia antibody titers were estimated using an ELISA, while C. trachomatis was detected in the urine using the nucleic acid amplification assay that included strand displacement amplification (SDA). We compared the results of 120 patients (64 men and 56 women), because the sensitivity of the method using urine samples from women has been reported to be as high as that using cervical samples. The serum antibody test results were considered to be positive when either one or both of the IgA and IgG antibodies were positive. RESULTS: The overall prevalence of positive results for the antibody test was 24.2% (14.1% for men and 35.7% for women), and that for the SDA method was 7.5% (3.1% for men and 12.5% for women). The concordance rate of the 2 tests was 81.7%, with a kappa statistic of 0.35 (95% CI, 0.10-0.59). Of the 9 subjects who were positive for C. trachomatis using the SDA assay, 1 had serum chlamydia IgA antibodies, 6 had IgG antibodies, 1 had both the antibodies, and 1 had no antibodies. On the other hand, of the 111 subjects who were negative for C. trachomatis, only 8 had chlamydia IgA antibodies, 5 had IgG antibodies, and 8 had both the antibodies. These results indicated there was no association between serum IgA antibodies and the presence of C. trachomatis. The presence of serum chlamydia antibodies was significantly higher in subjects with a past history of genital chlamydial infection than in those without a past history of infection (P<0.01). However, there was no difference in the results of the SDA assay between subjects with or without a previous infection. CONCLUSION: Thus, although serum chlamydia antibodies are generally measured at public health centers, tests for detecting C. trachomatis should also be used.
[Mh] Termos MeSH primário: Anticorpos Antibacterianos/análise
Infecções por Chlamydia/diagnóstico
Chlamydia trachomatis/imunologia
Chlamydia trachomatis/isolamento & purificação
Aconselhamento
Doenças Sexualmente Transmissíveis/diagnóstico
[Mh] Termos MeSH secundário: Adulto
Centros Comunitários de Saúde
Ensaio de Imunoadsorção Enzimática
Feminino
Humanos
Masculino
[Pt] Tipo de publicação:COMPARATIVE STUDY; ENGLISH ABSTRACT; JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Antibodies, Bacterial)
[Em] Mês de entrada:1408
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:140114
[St] Status:MEDLINE


  10 / 20128 MEDLINE  
              first record previous record
seleciona
para imprimir
Fotocópia
PubMed Central Texto completo
Texto completo
[PMID]:24378194
[Au] Autor:Souverein D; Euser SM; Ramaiah R; Narayana Gowda PR; Shekhar Gowda C; Grootendorst DC; Barot S; Jenniskens F; Kumar S; Kumar S; Den Boer JW
[Ad] Endereço:Department of Epidemiology, Regional Public Health Laboratory Kennemerland, Haarlem, The Netherlands; d.souverein@streeklabhaarlem.nl....
[Ti] Título:Reduction in STIs in an empowerment intervention programme for female sex workers in Bangalore, India: the Pragati programme.
[So] Source:Glob Health Action;6:22943, 2013.
[Is] ISSN:1654-9880
[Cp] País de publicação:Sweden
[La] Idioma:eng
[Ab] Resumo:BACKGROUND/OBJECTIVE: The Pragati programme is an on-going empowerment programme for female sex workers (FSWs) working and living in Bangalore, India. Pragati aims to reduce transmission of HIV and sexually transmitted infections (STIs) among FSWs. This study describes the STI incidence rate, contact rate, and condom use during follow-up years. DESIGN: Between April 2005 and November 2010, 20,330 FSWs participated in the programme. Outcome measures were programme exposure (number of contacts per person-year), STI incidence rate, and condom use. All analyses were stratified by year of follow-up. STIs were diagnosed by syndromic case management in either programme or referral clinics. We restricted our analyses to the period between April 2005 and July 2008 (when the majority of STIs were diagnosed in programme clinics), in order to minimise the possible influence of differences in STI diagnosis between clinic types. RESULTS: Results showed a significant increase of programme exposure (p-value for trend<0.001) and a significant decrease in the STI incidence rate (p-value for trend<0.001) over the follow-up time (between April 2005 and July 2008). Reported condom use at last paid sex increased from 77.6% in year 1 to 100% in year 4 of follow-up (p-value for trend<0.001). CONCLUSION: Our data seem to suggest that the Pragati programme had a positive effect on the STI incidence rate and condom use, possibly as a result of increased programme exposure. We recommend for future studies to invest more in the study design, type of data collection, and recording mechanisms before starting with an intervention. Incorporation of empowerment strategies as an approach in HIV prevention programmes can have a beneficial effect on the lives and livelihoods of FSWs.
[Mh] Termos MeSH primário: Preservativos/utilização
Infecções por HIV/prevenção & controle
Promoção da Saúde/organização & administração
Profissionais do Sexo
Doenças Sexualmente Transmissíveis/prevenção & controle
[Mh] Termos MeSH secundário: Adolescente
Adulto
Criança
Feminino
Humanos
Incidência
Índia/epidemiologia
Meia-Idade
Poder (Psicologia)
Avaliação de Programas e Projetos de Saúde
Doenças Sexualmente Transmissíveis/epidemiologia
Adulto Jovem
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1408
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:131231
[St] Status:MEDLINE
[do] DOI:10.3402/gha.v6i0.22943



página 1 de 2013 ir para página                         
   


Refinar a pesquisa
  Base de dados : MEDLINE Formulário avançado   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/OPAS/OMS - Centro Latino-Americano e do Caribe de Informação em Ciências da Saúde